NANOVIRICIDES, INC. Logo

NANOVIRICIDES, INC.

Clinical-stage biopharma developing broad-spectrum, nanomedicine-based antivirals.

NNVC | US

Overview

Corporate Details

ISIN(s):
US6300873022
LEI:
Country:
United States of America
Address:
1 CONTROLS DRIVE, 6484 SHELTON

Description

NanoViricides, Inc. is a clinical-stage biopharmaceutical company developing a novel class of nanomedicine-based antiviral therapeutics. The company's proprietary platform technology creates "nanoviricides," which are designed to be broad-spectrum drugs that viruses cannot easily evade through mutation. The technology is biomimetic, mimicking the host cell receptors that viruses use for entry. A nanoviricide is engineered to attract and bind to a virus particle, subsequently trapping and dismantling it to neutralize the threat. The company's development pipeline targets a wide range of viral infections, including respiratory viruses such as RSV, influenza, and coronaviruses, as well as herpesviruses (shingles, cold sores), HIV, and hemorrhagic fever viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-07-21 12:15
NanoViricides in BRileyFBR InfectiousDiseaseSummit
English 12.7 KB
2020-07-13 12:30
NanoViricides Raises $11.5M-Underwritten Offering
English 14.5 KB
2020-07-09 12:15
NanoViricides Prices $10million Public Offering
English 11.9 KB
2020-05-20 12:36
Strong Effectiveness of NanoViricides Drug
English 17.4 KB

Automate Your Workflow. Get a real-time feed of all NANOVIRICIDES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NANOVIRICIDES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NANOVIRICIDES, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CRONEX.CO.,LTD Logo
A CRO supplying biological species and bio-tissue materials for medical research.
South Korea
215570
C&R Research Inc. Logo
A full-service CRO providing clinical research for pharma and medical device companies.
South Korea
359090
Cte Group Spolka Akcyjna Logo
Diversified firm in HR services, corporate events, and composite materials.
Poland
LPS
curacle co., ltd. Logo
A clinical-stage biopharma developing drugs for intractable vascular diseases.
South Korea
365270
CytoMed Therapeutics Ltd Logo
Clinical-stage developer of off-the-shelf allogeneic cell immunotherapies for cancer.
United States of America
GDTC
Cyxone AB Logo
A clinical-stage biotech developing therapies for autoimmune and autoinflammatory diseases.
Sweden
CYXO
DARWIN AG Logo
Biotechnology firm creating personalized products from individual biological data.
Germany
7V0
DEINOVE Logo
Develops compounds from rare bacteria for cosmetics and new antibiotics.
France
ALDEI
Delta Drone Logo
Develops drone-based systems for the logistics, security, and military sectors.
France
ALDR
Delta-Fly Pharma, Inc. Logo
Biopharmaceutical firm developing novel anticancer drugs from existing components.
Japan
4598

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.